70 related articles for article (PubMed ID: 15242536)
21. CD4-binding site alterations in CCR5-using HIV-1 envelopes influencing gp120-CD4 interactions and fusogenicity.
Sterjovski J; Churchill MJ; Roche M; Ellett A; Farrugia W; Wesselingh SL; Cunningham AL; Ramsland PA; Gorry PR
Virology; 2011 Feb; 410(2):418-28. PubMed ID: 21216423
[TBL] [Abstract][Full Text] [Related]
22. HIV and SIV gp120 binding does not predict coreceptor function.
Baik SS; Doms RW; Doranz BJ
Virology; 1999 Jul; 259(2):267-73. PubMed ID: 10388651
[TBL] [Abstract][Full Text] [Related]
23. Theoretical studies on the interactions and interferences of HIV-1 glycoprotein gp120 and its coreceptor CCR5.
Da LT; Wu YD
J Chem Inf Model; 2011 Feb; 51(2):359-69. PubMed ID: 21284403
[TBL] [Abstract][Full Text] [Related]
24. Identification of anti-HIV components of salivary agglutinin (SAG).
Chow BE
Penn Dent J (Phila); 2002; 102():11. PubMed ID: 15487554
[No Abstract] [Full Text] [Related]
25. Review: Gp-340/DMBT1 in mucosal innate immunity.
Madsen J; Mollenhauer J; Holmskov U
Innate Immun; 2010 Jun; 16(3):160-7. PubMed ID: 20418254
[TBL] [Abstract][Full Text] [Related]
26. Antiviral activities in human saliva.
Malamud D; Abrams WR; Barber CA; Weissman D; Rehtanz M; Golub E
Adv Dent Res; 2011 Apr; 23(1):34-7. PubMed ID: 21441478
[TBL] [Abstract][Full Text] [Related]
27. Staphylococcus aureus SasA is responsible for binding to the salivary agglutinin gp340, derived from human saliva.
Kukita K; Kawada-Matsuo M; Oho T; Nagatomo M; Oogai Y; Hashimoto M; Suda Y; Tanaka T; Komatsuzawa H
Infect Immun; 2013 Jun; 81(6):1870-9. PubMed ID: 23439307
[TBL] [Abstract][Full Text] [Related]
28. HIV infection of fetal human astrocytes: the potential role of a receptor-mediated endocytic pathway.
Hao HN; Lyman WD
Brain Res; 1999 Mar; 823(1-2):24-32. PubMed ID: 10095008
[TBL] [Abstract][Full Text] [Related]
29. Leucine-rich repeats of bacterial surface proteins serve as common pattern recognition motifs of human scavenger receptor gp340.
Loimaranta V; Hytönen J; Pulliainen AT; Sharma A; Tenovuo J; Strömberg N; Finne J
J Biol Chem; 2009 Jul; 284(28):18614-23. PubMed ID: 19465482
[TBL] [Abstract][Full Text] [Related]
30. HIV envelope binding by macrophage-expressed gp340 promotes HIV-1 infection.
Cannon G; Yi Y; Ni H; Stoddard E; Scales DA; Van Ryk DI; Chaiken I; Malamud D; Weissman D
J Immunol; 2008 Aug; 181(3):2065-70. PubMed ID: 18641344
[TBL] [Abstract][Full Text] [Related]
31. Bacteria binding by DMBT1/SAG/gp-340 is confined to the VEVLXXXXW motif in its scavenger receptor cysteine-rich domains.
Bikker FJ; Ligtenberg AJ; End C; Renner M; Blaich S; Lyer S; Wittig R; van't Hof W; Veerman EC; Nazmi K; de Blieck-Hogervorst JM; Kioschis P; Nieuw Amerongen AV; Poustka A; Mollenhauer J
J Biol Chem; 2004 Nov; 279(46):47699-703. PubMed ID: 15355985
[TBL] [Abstract][Full Text] [Related]
32. An electrochemiluminescence assay for gp340 (DMBT1).
Barber C; Weissman D; Barnhart K; Dalvi M; Abrams WR; Malamud D
Anal Biochem; 2013 Sep; 440(1):78-80. PubMed ID: 23727557
[TBL] [Abstract][Full Text] [Related]
33. Calcium-binding properties of SSP-5, the Streptococcus gordonii M5 receptor for salivary agglutinin.
Duan Y; Fisher E; Malamud D; Golub E; Demuth DR
Infect Immun; 1994 Dec; 62(12):5220-6. PubMed ID: 7960097
[TBL] [Abstract][Full Text] [Related]
34. One-step FPLC-size-exclusion chromatography procedure for purification of rDMBT1 6 kb with increased biological activity.
Tuttolomondo M; Hansen PL; Mollenhauer J; Ditzel HJ
Anal Biochem; 2018 Feb; 542():16-19. PubMed ID: 29169777
[TBL] [Abstract][Full Text] [Related]
35. Possible transmission of HIV Infection due to human bite.
Deshpande AK; Jadhav SK; Bandivdekar AH
AIDS Res Ther; 2011 Mar; 8():16. PubMed ID: 21453452
[TBL] [Abstract][Full Text] [Related]
36. gp340 expressed on human genital epithelia binds HIV-1 envelope protein and facilitates viral transmission.
Stoddard E; Cannon G; Ni H; Karikó K; Capodici J; Malamud D; Weissman D
J Immunol; 2007 Sep; 179(5):3126-32. PubMed ID: 17709527
[TBL] [Abstract][Full Text] [Related]
37. Determinants of Tenascin-C and HIV-1 envelope binding and neutralization.
Mangan RJ; Stamper L; Ohashi T; Eudailey JA; Go EP; Jaeger FH; Itell HL; Watts BE; Fouda GG; Erickson HP; Alam SM; Desaire H; Permar SR
Mucosal Immunol; 2019 Jul; 12(4):1004-1012. PubMed ID: 30976088
[TBL] [Abstract][Full Text] [Related]
38. Increased expression of deleted in malignant brain tumors (DMBT1) gene in precancerous gastric lesions: Findings from human and animal studies.
Garay J; Piazuelo MB; Lopez-Carrillo L; Leal YA; Majumdar S; Li L; Cruz-Rodriguez N; Serrano-Gomez SJ; Busso CS; Schneider BG; Delgado AG; Bravo LE; Crist AM; Meadows SM; Camargo MC; Wilson KT; Correa P; Zabaleta J
Oncotarget; 2017 Jul; 8(29):47076-47089. PubMed ID: 28423364
[TBL] [Abstract][Full Text] [Related]
39. Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study.
Patyka M; Malamud D; Weissman D; Abrams WR; Kurago Z
PLoS One; 2015; 10(7):e0132942. PubMed ID: 26172445
[TBL] [Abstract][Full Text] [Related]
40. The calcium-induced conformation and glycosylation of scavenger-rich cysteine repeat (SRCR) domains of glycoprotein 340 influence the high affinity interaction with antigen I/II homologs.
Purushotham S; Deivanayagam C
J Biol Chem; 2014 Aug; 289(32):21877-87. PubMed ID: 24923446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
